Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosisAnimesh Pardanani, Jason R Gotlib, Catriona Jamieson, et al.
Blood|June 19, 2008
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cellsWinnie F Tam, Ting-Lei Gu, Jing Chen, et al.
Experimental Hematology|December 24, 2014
Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant miceSamuel J Taylor, Christine B F Thien, Samantha A Dagger, et al.
Cell Stem Cell|July 14, 2015
Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor CellsXiongwei Cai, Long Gao, Li Teng, et al.
Experimental Hematology|August 30, 2008
Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarrayNorihiko Kawamata, Seishi Ogawa, Go Yamamoto, et al.
Cancer|December 22, 2005
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia veraAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.
Blood|December 14, 2011
KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in miceLing Zhao, Jan J Melenhorst, Lemlem Alemu, et al.
Blood|February 29, 2008
Structural and numerical variation of FLT3/ITD in pediatric AMLSoheil Meshinchi, Derek L Stirewalt, Todd A Alonzo, et al.
American Journal of Human Genetics|June 15, 2007
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarraysGo Yamamoto, Yasuhito Nannya, Motohiro Kato, et al.
Blood|May 6, 2006
Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like diseaseIris T Chan, Jeffery L Kutok, Ifor R Williams, et al.
Pageof 18